Overview
- 8 FDA inspections are on record.
- 4 inspections produced a Form 483.
- The most recent recorded inspection date is 2018-12-06.
At a glance
Inspections
8
Form 483s
4
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 12 Nov 2018 – 6 Dec 2018 | Human Drugs | 483 | View 483 → |
| 20 Jun 2018 – 3 Jul 2018 | Human Drugs | 483 | On file |
| 21 Feb 2017 – 28 Feb 2017 | Human Drugs | 483 | View 483 → |
| 14 Sep 2015 – 6 Oct 2015 | Human Drugs | Clean | |
| 28 Sep 2011 | Not recorded | 483 | On file |
| 25 Sep 2009 | Not recorded | Clean | |
| 30 Sep 2005 | Not recorded | Clean | |
| 16 Jan 2001 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Kent A Conforti2 insp.
Anthony N Onianwa2 insp.
Victoria M Daddeo1 insp.
Michelle M Noe Varga1 insp.
Maya M Davis1 insp.
Mark R Mcclain1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 312.50 | Cited across public-safe Form 483 observations | 3x |
Full site report
Get the verbatim findings behind Boehringer Ingelheim Pharmaceuticals, Inc.'s 4 Form 483s
Recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat